Nutra Pharma Announces Addition of Maj. Gen. Kenneth Dowd to its Advisory Board
August 30, 2016 Nutra Pharma is announcing today the creation of a Military and Veteran's business segment to be assisted by Maj. Gen. Kenneth Dowd, US Army (retired). August 30, 2016 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, announced today the appointment of Maj. Gen. Kenneth Dowd, US Army (Ret.) as Strategic Advisor for the Company'
Nutra Pharma Announces Additions to the Board of Directors and Management Team
August 16, 2016 Nutra Pharma is announcing the addition of Dan Oran to their Board of Directors and Dale Vanderputten, PhD as their Chief Scientific Officer August 16, 2016 -- Coral Springs, Florida -- Nutra Pharma Corporation (OTCQB: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market, and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneurop